Cargando…
(+)-Methyl 3β-acetoxy-13-carboxy-19-hydroxy-11-oxo-C-norolean-18-en-30-oate γ-lactone
The title compound, C(33)H(46)O(7), is an unusual oxydation product of the therapeutic agent glycyrrhetinic acid that has, in comparison to the latter, a distinctly altered triterpene structure with one five- and four six-membered carbocycles complemented by a γ-lactone ring with a spiro-junction an...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
International Union of Crystallography
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2983216/ https://www.ncbi.nlm.nih.gov/pubmed/21587575 http://dx.doi.org/10.1107/S1600536810036901 |
Sumario: | The title compound, C(33)H(46)O(7), is an unusual oxydation product of the therapeutic agent glycyrrhetinic acid that has, in comparison to the latter, a distinctly altered triterpene structure with one five- and four six-membered carbocycles complemented by a γ-lactone ring with a spiro-junction and a ring double bond. The junction between the five-membered ring C, a cyclopentanone ring, and the six-membered ring D, previously in question, was found to be cis, confirming earlier structure assignments based solely on chemical transformations. In the solid state, the compound exhibits five intra- and four intermolecular C—H⋯O interactions with H⋯O distances less than or equal to 2.70 Å and C—H⋯O greater than 100°. |
---|